Looking ahead - Make sure you know what's cooking in biotech in 1H2012!

In order to take advantage of biotech stock/options trading, it is paramount to know which companies are the centre of attention within the biotech community. These companies tend to be the ones facing scrutiny by the FDA panel and those to be dealt FDA drug approval decision (PDUFA). With skyrocketing volatility, the stocks of these companies are perfect for trading. Mark these important dates down on your calendar as a start. Detailed analysis of each company and trading roadmap will follow as the date of each event approaches. Good luck and have a fulfilling and prosperous 2012!